Best Alzheimer's and Dementia Research Grants in Alabama

Researchers and early-career scientists working on Alzheimer’s and dementia in Alabama can apply for BrightFocus Foundation’s Alzheimer’s Disease Research Grants, awarding US $200,000 - US $300,000 for pioneering studies. Eligible applicants include postdoctoral fellows and new investigators with recent MD, PhD, or equivalent degrees, at institutions in the U.S. or abroad.

The JTMF Foundation Grant focuses on improving the lives of individuals in need, particularly in the Pacific Northwest. By partnering with organizations addressing immediate needs and long-term challenges, the foundation supports children, older adults, veterans, and individuals with intellectual and developmental disabilities. Guided by Catholic values, JTMF aims to empower communities while seeking innovative solutions to societal issues. Organizations that align with these focus areas are encouraged to connect, fostering a collaborative effort towards meaningful impact.

Alabama nonprofits that are Alzheimer’s Foundation of America member organizations can apply for $6,000 bi-annual grants to support new or existing programs serving people affected by Alzheimer’s and related dementias. Eligible uses include administrative costs, staff salaries and training, occupancy, and supplies or equipment, which may benefit organizations providing dementia care, support, or education.

Universities, research institutions, and similar organizations in Alabama and other U.S. locations can obtain funding for postbaccalaureate research education programs focused on Alzheimer’s disease and related dementias. US Dept. of Health & Human Services: National Institutes of Health supports intensive one-to-two-year research experiences, mentorship, and professional development for recent graduates pursuing AD/ADRD research careers, with awards up to US $400,000.

Educational institutions and research organizations in Alabama developing summer programs in Alzheimer’s and dementia research for high school students, undergraduates, or science teachers can apply for up to US $200,000 from the National Institutes of Health. Funding supports hands-on AD/ADRD research experiences plus complementary STEM education and professional development activities that build the future dementia research workforce.

Alabama Alzheimer’s and dementia researchers at early-career, assistant professor–level positions can access funding to develop preliminary or pilot data, test procedures, and build hypotheses in dementia and Alzheimer’s disease. The Alzheimer’s Association offers US $70,000 - US $200,000 for projects across basic, translational, clinical, psychosocial, neuroimaging, epidemiology, care, or health equity research.

Alabama dementia and Alzheimer’s organizations can access funding through Sephardic Home For The Aged Foundation to improve care, support, and quality of life for older adults with brain degenerative diseases. Eligible applicants are 501(c)(3) nonprofits or fiscally sponsored projects operating at least two years; individuals and universities are not supported.

Postdoctoral researchers conducting Alzheimer’s and dementia research in Alabama can receive up to US $200,000 to advance understanding, diagnosis, or treatment. The Alzheimer’s Association Research Fellowship for All supports early career investigators under established mentors and encourages applications from individuals from underrepresented groups pursuing dementia-related research careers.

Clinician scientists practicing in patient-facing or diagnostic fields and conducting Alzheimer’s or dementia research can apply for up to US $250,000, including those based in Alabama. Grants from Alzheimer’s Association help support training and career development for licensed clinicians, with encouragement for individuals from underrepresented groups to pursue dementia-focused research careers.

With a mission to support dementia care, Alzheimer’s Foundation of America provides Alabama Alzheimer’s-related nonprofits with US $25,000 for innovative programs improving life for individuals with Alzheimer’s or related dementias and their families. Only AFA nonprofit member organizations may apply, and funds can cover implementation costs such as staff, training, occupancy, supplies, and equipment.

Public safety agencies in Alabama running dementia-related wandering prevention or public safety programs can apply for the Project Lifesaver International Grant, with awards of US $6,000. Focused on dementia and Alzheimer’s disease, the Alzheimer’s Foundation of America supports administrative costs, staff training, supplies, equipment, and community education for these initiatives.

Nonprofit AFA member organizations providing dementia and Alzheimer’s respite services in Alabama can apply for Alzheimer’s Foundation of America’s Milton & Phyllis Berg Family Respite Care Grants; awards US $6,000 for respite care scholarships. Funding can cover supplies, equipment, capacity building, administrative expenses, and staff training to better support caregivers and care recipients.

Researchers and research institutions conducting imaging studies on Alzheimer’s and other neurodegenerative diseases in Alabama may be eligible for this pilot funding program. Grants from Alzheimer's Association help Alabama dementia and Alzheimer’s research efforts develop novel imaging tools and innovative imaging data analysis, with awards of US $200,000 over one year for up to three projects.

Academic and research institutions studying olfactory decline in aging, Alzheimer’s disease, and related dementias in Alabama can access funding via the National Institutes of Health. Focused on mechanisms linking smell loss to AD/ADRD and aging, this upcoming R01 NOFO will support cellular, molecular, imaging, physiological, omics, and related approaches.

Focused on dementia and Alzheimer’s disease research, this upcoming NIH Notice of Funding Opportunity invites investigators to study cerebellar contributions to cognitive and affective functions in aging and AD/ADRD. Alabama research institutions and teams may be eligible to propose basic, translational, or data-driven projects, including potential intervention targets to promote cognitive reserve.

Families needing in-home respite care for loved ones with Alzheimer’s or other dementias in the Boyertown Area School District can apply for the Margaret B. Moeller Memorial Fund, offering US $200 - US $3,000 for home care companions and aides. Alabama dementia-focused nonprofits may know eligible families with ties to this district.

Alabama Alzheimer’s and dementia research institutions and teams can access funding through the National Institutes of Health for preclinical validation and early-stage drug discovery. This upcoming National Institute on Aging opportunity will support rigorous work on novel Alzheimer’s and related dementia drug targets, including small molecules, biologics, and emerging therapeutic modalities across eligible U.S. locations.

Research institutions studying mechanisms of neurodegeneration in Alzheimer’s disease-related dementias can apply for collaborative “Center without Walls” consortia funding, open to U.S. sites including Alabama. National Institutes of Health, via NINDS, plans to support interdisciplinary teams using advanced technologies and disease-relevant models to uncover ADRD mechanisms, therapeutic targets, biomarkers, and factors influencing susceptibility and resilience.

Research institutions studying Alzheimer’s and dementia mechanisms, including exposomic and environmental neuroscience, may be eligible for funding to investigate how neural exposome factors drive ADRD pathology and resilience in Alabama and nationwide. National Institutes of Health, via NINDS, supports mechanistic, translational, and human subjects research on synergistic exposures and pathways across the lifespan.

Research institutions and investigators working on Alzheimer’s and dementia can apply for National Institutes of Health funding to validate new therapeutic targets, including in Alabama. This phased award from NINDS supports technology and model development, then multi-lab cross-validation of target modulation to de-risk future translational research for Alzheimer’s disease-related dementias.

Research institutions and similar organizations in Alabama studying dementia and Alzheimer’s disease care pathways and early detection can apply for the Alzheimer’s Association’s Health Services Research in Alzheimer’s Disease and Related Disorders program, with awards up to US $250,000. Funding supports rigorous health services research on detection, diagnosis, and post-diagnostic dementia care.

The NIH Blueprint for Neuroscience Research Network aims to enhance foundational research on human consciousness, addressing critical biomedical issues such as coma and dementia. By fostering a collaborative framework among 14 NIH institutes, the initiative seeks to improve diagnosis and treatment of neurological disorders through interdisciplinary approaches. Key objectives include detecting consciousness in minimally responsive patients, enhancing understanding of sleep disorders, and exploring new methodologies. This effort will ultimately strengthen U.S. leadership in neuroscience and improve patient outcomes.

The DoW Alzheimer’s Transforming Research Award supports innovative research aimed at reducing the risk and preventing Alzheimer’s disease and related dementias. It emphasizes projects that enhance understanding of risk factors and develop effective risk reduction strategies. Clinical research is permitted, but trials and animal studies are not. Collaboration and preliminary data are essential for proposal consideration, and an option for multiple principal investigators is available to foster partnerships.

The FY26 Alzheimer’s Research Program's Transforming Diagnosis Award (TrDA) promotes innovative research aimed at overcoming significant barriers to accurate diagnosis and monitoring of Alzheimer's disease. This award encourages community collaboration and requires preliminary data. It supports studies leveraging existing cohorts, especially those including individuals aged 65 and younger. The TrDA also offers a partnership option for multiple principal investigators, fostering collaborative research efforts while ensuring at least one independent investigator meets eligibility criteria.

The DoW Alzheimer’s Transforming Care Award aims to support innovative clinical research and trials enhancing dementia care for individuals with Alzheimer’s disease. This funding opportunity encourages collaborative partnerships and requires preliminary data, focusing on interventions that do not solely test pharmacological solutions. Community collaboration is essential, and studies leveraging existing cohorts, including those with younger participants, are encouraged. The award supports both new and existing partnerships among principal investigators.

The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) aims to create a secure, scalable cloud platform for genetic data related to Alzheimer’s disease. This initiative will enhance data accessibility, promote interoperability, and support rigorous research practices. By facilitating collaboration and providing robust analytical tools, the platform will maximize the scientific impact of AD/ADRD research, aligning with NIH goals for transparent and reproducible science, while addressing recommendations for broad access to high-value datasets.

The National Institute on Aging (NIA) is inviting applications for the Alzheimer's Drug-Development Program (U01 Clinical Trial Optional). This initiative seeks to support pre-clinical and early-stage clinical development of innovative drug candidates aimed at preventing Alzheimer's disease or treating its symptoms. The program encourages collaboration among researchers and aims to enhance the therapeutic pipeline for AD through targeted approaches. This notice allows potential applicants time to prepare robust projects.